Researchers believe they have found the first blood biomarker for diagnosing myocarditis, sharing their findings in the New England Journal of Medicine.

Researchers will be tracking COVID-19's impact on healthcare for many years to come.

Researchers found that the SGLT2 inhibitor had similar value among patients with and without diabetes, sharing their findings in JAMA Cardiology.

After studying the latest research, a veteran cardiologist is no longer recommending fish oil supplements to his patients.

Researchers examined data from nearly 1,200 PCI patients, sharing their findings in JACC: Cardiovascular Interventions.

It's not necessarily that people should never eat meat—but eating it for breakfast instead of dinner, for example, can make a significant difference. 

Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI. 

The findings could represent a significant change in patient care, specialists wrote, but "femoral believers" may not be swayed until additional data can be reviewed. 

Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. 

Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”

When the network interpreted complete videos from 42 consecutive patients, it boosted detection rates by as much as 50% over physician-alone reads.

Pylarify is a F 18-labeled, prostate-specific membrane antigen targeted PET agent used to pinpoint suspected metastasis or recurrence of the disease.